1) soluble antitumor agents
水溶性抗肿瘤药物
2) poorly soluble antineoplastic
难溶性抗肿瘤药物
1.
Block copolymer micelles as delivery system for poorly soluble antineoplastic carrier;
难溶性抗肿瘤药物载体——嵌段共聚物胶束
3) phytogenic antineoplastic agents
植物性抗肿瘤药
4) Anti-tumour activity of drug
药物抗肿瘤活性
5) Antitumor drug
抗肿瘤药物
1.
Advance of several types of important marine antitumor drugs;
几类重要的海洋抗肿瘤药物研究进展
2.
Application of polymer nanoparticles to antitumor drug delivery system;
聚合物纳米粒子作为抗肿瘤药物载体的应用
3.
Study on different educational level nursing students recognition and compliance with the occupational prevention while handling antitumor drugs;
不同学历护生对抗肿瘤药物职业防护的认知和依从性研究
6) Antineoplastic Agents
抗肿瘤药物
1.
Through analyzing the whole of using Antineoplastic Agents :the market portion,increase rate,centralize degree and calculate in 257 hospitals of the 16 national important cities in this text,we can know the Antineoplastic Agents mar.
本文通过对全国16个重点城市257家医院的抗肿瘤医院用药总体情况进行市场份额、增长率、品种潜力、各类别的抗肿瘤药物市场份额、各品种的抗肿瘤药物市场份额以及市场集中度等方面进行分析,并结合政府出台的一系列的医药政策的影响,对目前抗肿瘤药物的医院市场情况,市场未来预测以及抗肿瘤药物的未来研发方向等进行了探讨。
2.
Effects of antineoplastic agents on endocrine system are common, but it is difficult to identify since clinical complaints are subtle, and even more difficult to relate a particular chemotherapeutic regimen to the induced endocrine disturb.
抗肿瘤药物所致的内分泌紊乱在临床上并不少见,但由于其临床表现隐匿,症状错综复杂,临床上不易辨认,特别是与特定化疗药物的关系,难以鉴别。
3.
OBJECTIVE To enhance the rational drug use of intravenous antineoplastic agents.
目的促进抗肿瘤药物静脉用药的合理性。
补充资料：抗代谢类抗肿瘤药物
抗代谢类抗肿瘤药物
antimetabolite agents
此类抗癌药对核酸代谢物与酶结合反应有相互竞争作用，影响与阻断了核酸的合成，如氟尿嘧啶、甲氨蝶呤、呋喃氟尿嘧啶、阿糖胞苷等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条